Hangwen Li

3.1k total citations · 1 hit paper
22 papers, 2.1k citations indexed

About

Hangwen Li is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Hangwen Li has authored 22 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Infectious Diseases. Recurrent topics in Hangwen Li's work include Cancer Cells and Metastasis (8 papers), RNA Interference and Gene Delivery (5 papers) and Immunotherapy and Immune Responses (5 papers). Hangwen Li is often cited by papers focused on Cancer Cells and Metastasis (8 papers), RNA Interference and Gene Delivery (5 papers) and Immunotherapy and Immune Responses (5 papers). Hangwen Li collaborates with scholars based in China, United States and Macao. Hangwen Li's co-authors include Dean G. Tang, Xin Chen, Tammy Calhoun‐Davis, Collene Jeter, Sofia Honorio, Lubna Patrawala, Bigang Liu, Jason F. Wiggins, David T. Brown and Can Liu and has published in prestigious journals such as Nature Medicine, PLoS ONE and Cancer Research.

In The Last Decade

Hangwen Li

21 papers receiving 2.1k citations

Hit Papers

The microRNA miR-34a inhibits prostate cancer stem cells ... 2011 2026 2016 2021 2011 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
    2011 1.1k citations Can Liu, Kevin Kelnar et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hangwen Li China 13 1.4k 1.1k 814 470 188 22 2.1k
Kiera Rycaj United States 22 1.4k 1.0× 572 0.5× 770 0.9× 433 0.9× 288 1.5× 29 2.2k
Hui Sun Leong United Kingdom 25 1.1k 0.8× 726 0.7× 658 0.8× 231 0.5× 267 1.4× 40 1.9k
Mirjam C. Boelens Netherlands 16 1.0k 0.7× 638 0.6× 447 0.5× 264 0.6× 201 1.1× 29 1.4k
Mohit Sachdeva United States 15 1.5k 1.0× 1.2k 1.1× 429 0.5× 163 0.3× 157 0.8× 26 2.0k
Bo Su China 21 1.4k 1.0× 1.1k 1.0× 457 0.6× 400 0.9× 181 1.0× 56 2.0k
Randolph S. Watnick United States 16 788 0.5× 398 0.4× 662 0.8× 161 0.3× 255 1.4× 27 1.4k
André Filipe Vieira Portugal 18 793 0.5× 456 0.4× 741 0.9× 165 0.4× 104 0.6× 29 1.5k
Alison M. Karst United States 18 927 0.6× 407 0.4× 578 0.7× 150 0.3× 200 1.1× 21 1.8k
Emre Sayan United Kingdom 31 1.9k 1.3× 883 0.8× 1.2k 1.5× 176 0.4× 280 1.5× 76 2.6k
Man-Zhi Li China 22 1.1k 0.8× 490 0.5× 813 1.0× 146 0.3× 205 1.1× 30 1.8k

Countries citing papers authored by Hangwen Li

Since Specialization
Citations

This map shows the geographic impact of Hangwen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangwen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangwen Li more than expected).

Fields of papers citing papers by Hangwen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hangwen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangwen Li. The network helps show where Hangwen Li may publish in the future.

Co-authorship network of co-authors of Hangwen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hangwen Li. A scholar is included among the top collaborators of Hangwen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hangwen Li. Hangwen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Junfeng, Z. Q. Qiu, Hangwen Li, et al.. (2025). Electrochemical integrated driven patterning of liquid metal/MXene hydrogel electrodes for stretchable microsupercapacitors. Energy storage materials. 84. 104764–104764.
2.
Lu, Huanhuan, Jinbo Xiao, Jingdong Song, et al.. (2025). The Immunogenicity of Coxsackievirus A6 (D3a Sub‐Genotype) Virus‐Like Particle and mRNA Vaccines. Journal of Medical Virology. 97(2). e70201–e70201. 2 indexed citations
3.
Huang, Lei, Fanfan Zhao, Muye He, et al.. (2024). An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants. Journal of Controlled Release. 366. 479–493. 12 indexed citations
4.
Du, Pei, Lei Huang, Fanfan Zhao, et al.. (2024). Broad-spectrum Delta-BA.2 tandem-fused heterodimer mRNA vaccine delivered by lipopolyplex. PLoS Pathogens. 20(4). e1012116–e1012116. 7 indexed citations
5.
6.
Yang, Jianmei, Ruizhong Shen, Chengguang Zhang, et al.. (2023). A single immunization with core–shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs. Emerging Microbes & Infections. 12(2). 2270081–2270081. 21 indexed citations
7.
Meng, Chaoyang, et al.. (2022). An mRNA vaccine elicits STING-dependent antitumor immune responses. Acta Pharmaceutica Sinica B. 13(3). 1274–1286. 28 indexed citations
8.
Tan, Yong, Shuaiyao Lu, Bo Wang, et al.. (2022). Single‐cell transcriptome atlas reveals protective characteristics of COVID‐19 mRNA vaccine. Journal of Medical Virology. 95(1). e28161–e28161. 6 indexed citations
9.
Meng, Chaoyang, Zhe Chen, Junhua Mai, et al.. (2021). Virus‐Mimic mRNA Vaccine for Cancer Treatment. Advanced Therapeutics. 4(11). 2100144–2100144. 14 indexed citations
10.
Huang, Lei, Luyao Zhang, Weiwei Li, et al.. (2020). Advances in Development of mRNA-Based Therapeutics. Current topics in microbiology and immunology. 440. 147–166. 7 indexed citations
11.
Rycaj, Kiera, Hangwen Li, Jianjun Zhou, Xin Chen, & Dean G. Tang. (2017). Cellular determinants and microenvironmental regulation of prostate cancer metastasis. Seminars in Cancer Biology. 44. 83–97. 56 indexed citations
12.
Liu, Xin, Xin Chen, Kiera Rycaj, et al.. (2015). Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 6(27). 23959–23986. 58 indexed citations
13.
Putluri, Nagireddy, Hangwen Li, Todd M. Morgan, et al.. (2015). Platelet-Synthesized Testosterone in Men with Prostate Cancer Induces Androgen Receptor Signaling. Neoplasia. 17(6). 490–496. 10 indexed citations
14.
Roca, Hernan, James R. Hernandez, Richard C. McEachin, et al.. (2013). Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer. PLoS ONE. 8(10). e76773–e76773. 192 indexed citations
15.
Qin, Jichao, Xin Liu, Brian Laffin, et al.. (2012). The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration. Cell stem cell. 10(5). 556–569. 243 indexed citations
16.
Li, Hangwen & Dean G. Tang. (2011). Prostate cancer stem cells and their potential roles in metastasis. Journal of Surgical Oncology. 103(6). 558–562. 57 indexed citations
17.
Liu, Can, Kevin Kelnar, Bigang Liu, et al.. (2011). The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Medicine. 17(2). 211–215. 1136 indexed citations breakdown →
18.
Yan, Hong, Xin Chen, Qiuping Zhang, et al.. (2011). Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44+ Cells and Evidence for Epigenetic Mechanisms. PLoS ONE. 6(9). e24397–e24397. 42 indexed citations
19.
Li, Hangwen, Ming Jiang, Sofia Honorio, et al.. (2009). Methodologies in Assaying Prostate Cancer Stem Cells. Methods in molecular biology. 568. 85–138. 30 indexed citations
20.
Li, Hangwen, Xin Chen, Tammy Calhoun‐Davis, Kent Claypool, & Dean G. Tang. (2008). PC3 Human Prostate Carcinoma Cell Holoclones Contain Self-renewing Tumor-Initiating Cells. Cancer Research. 68(6). 1820–1825. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiera Rycaj Breakdown of academic impact, for papers by Hui Sun Leong Breakdown of academic impact, for papers by Mirjam C. Boelens Breakdown of academic impact, for papers by Mohit Sachdeva Breakdown of academic impact, for papers by Bo Su Breakdown of academic impact, for papers by Randolph S. Watnick Breakdown of academic impact, for papers by André Filipe Vieira Breakdown of academic impact, for papers by Alison M. Karst Breakdown of academic impact, for papers by Emre Sayan Breakdown of academic impact, for papers by Man-Zhi Li
Rankless by CCL
2026